Delirium in the geriatric unit: Proton-pump inhibitors and other risk factors

Clinical Interventions in Aging

Volumn 11, Issue , 2016, Pages 397-405

  Otremba, Iwona ^a   Wilczyński, Krzysztof ^a   Szewieczek, Jan ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Comprehensive geriatric assessment; Confusion Assessment Method; Delirium; Delirium O Meter; Geriatric ward; Richmond Agitation Sedation Scale

Indexed keywords

PROTON PUMP INHIBITOR;

ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELIRIUM; DEMENTIA; DRUG USE; ELECTROCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; GERIATRIC ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT TRANSPORT; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; RISK FACTOR; STRUCTURED INTERVIEW; THORAX RADIOGRAPHY; UNIVERSITY HOSPITAL; FALLING; HOSPITALIZATION; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN MEASUREMENT; POLAND; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DELIRIUM; DEMENTIA; FEMALE; GERIATRIC ASSESSMENT; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN MEASUREMENT; PATIENT TRANSFER; POLAND; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 84962343672     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S103349     Document Type: Article

References (68)

1. Jitapunkul S, Pillay I, Ebrahim S. Delirium in newly admitted elderly patients: a prospective study. Q J Med. 1992;83:307–314.
2. Witlox J, Eurelings LS, de Jonghe JF, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304:443–451.
3. Han JH, Eden S, Shintani A, et al. Delirium in older emergency depart­ment patients is an independent predictor of hospital length of stay. Acad Emerg Med. 2011;18:451–457.
4. Fick DM, Steis MR, Waller JL, Inouve SK. Delirium superimposed on dementia is associated with prolonged length of stay and poor outcomes in hospitalized older adults. J Hosp Med. 2013;8:500–505.
5. Inouye SK, Westendorp RGJ, Saczynski JS. Delirium in elderly people. Lancet. 2014;383:911–922.
6. Flaherty JH. Delirium. In: Sinclair AJ, Morley JE, Vellas B, editors. Pathy’s Principles and Practive of Geriatric Medicine. Vol 2. 5th ed. Chichester, UK: Willey-Blackwell; 2012;844–846.
7. Noriega FJ, Vidán MT, Sánchez E, et al. Incidence and impact of delirium on clinical and functional outcomes in older patients hospitalized for acute cardiac diseases. Am Heart J. 2015;170:938–944.
8. Leslie E, Cerin E. Are perceptions of the local environment related to neighbourhood satisfaction and mental health in adults? Prev Med. 2008;47:273–278.
9. Bail K, Goss J, Draper B, et al. The cost of hospital-acquired complica­tions for older people with and without dementia; a retrospective cohort study. BMC Health Serv Res. 2015;15:91.
10. Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35:350–364.
11. Ryan DJ, O’Regan NA, Caoimh RÓ, et al. Delirium in an adult acute hospital population: predictors, prevalence and detection. BMJ Open. 2013;3:pii: e001772.
12. Martinez F, Tobar C, Hill N. Preventing delirium: should non-pharmacological, multicomponent interventions be used? A system­atic review and meta-analysis of the literature. Age Ageing. 2015;44:196–204.
13. Hshieh TT, Yue J, Oh E, et al. Effectiveness of multicomponent non­pharmacological delirium interventions: a meta-analysis. JAMA Intern Med. 2015;175:512–520.
14. Clegg A, Siddiqi N, Heaven A, Young J, Holt R. Interventions for pre­venting delirium in older people in institutional long-term care. Coch Dat Syst Rev. 2014;1:CD009537.
15. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63:2227–2246.
16. Avelino-Silva TJ, Farfel JM, Curiati JA, et al. Comprehensive geriatric assessment predicts mortality and adverse outcomes in hospitalized older adults. BMC Geriatr. 2014;14:129.
17. Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340:669–676.
18. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941–948.
19. de Jonghe JF, Kalisvaart KJ, Timmers JF, Kat MG, Jackson JC. Delirium-O-Meter: a nurses’ rating scale for monitoring delirium severity in geriatric patients. Int J Geriatr Psychiatry. 2005;20:1158–1166.
20. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166:1338–1344.
21. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
22. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5:165–173.
23. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Maryland State Med J. 1965;14:56–61.
24. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontol. 1969;9:179–186.
25. Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the “get-up and go” test. Arch Phys Med Rehabil. 1986;67:387–389.
26. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of demen­tia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnos­tic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–269.
27. Joyce CR, Zutshi DW, Hrubes V, et al. Comparison of fixed interval and visual analogue scales for rating chronic pain. Eur J Clin Pharmacol. 1975;8:415–420.
28. Hjermstad MJ, Fayers PM, Haugen DF, et al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011;41:1073–1093.
29. Wary B. Doloplus-2, a scale for pain measurement. Soins Gerontol. 2011;19:25–27.
30. Lefebvre-Chapiro S. The Doloplus-2 scale – evaluating pain in the elderly. Eur J Palliat Care. 2001;8:191–194.
31. Goldberg A, Straus SE, Hamid JS, et al. Room transfers and the risk of delirium incidence amongst hospitalized elderly medical patients: a case-control study. BMC Geriatr. 2015;15:70–78.
32. Yue J, Tabloski P, Dowal SL, et al. NICE to HELP: operationalizing National Institute for Health and Clinical Excellence guidelines to improve clinical practice. J Am Geriatr Soc. 2014;62:754–761.
33. Leonard MM, Agar M, Spiller JA, et al. Delirium diagnostic and clas­sification challenges in palliative care: subsyndromal delirium, comor­bid delirium-dementia, and psychomotor subtypes. J Pain Symptom Manage. 2014;48:199–214.
34. Kim SY, Kim SW, Kim JM, et al. Differential associations between delirium and mortality according to delirium subtype and age: a pro­spective cohort study. Psychosom Med. 2015;77:903–910.
35. Fong TG, Davis D, Growdon ME, et al. The interface between delirium and dementia in elderly adults. Lancet Neurol. 2015;14:823–832.
36. Davies EA, O’Mahony MS. Adverse drug reactions in special populations – the elderly. Br J Clin Pharmacol. 2015;80:796–807.
37. Kishi T, Hirota T, Matsunaga S, et al. Antipsychotic medications for the treatment of delirium: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry. 2015. Epub 2015 Sep 4. doi:/jnnp-2015-311049.
38. Koponen M, Tolppanen AM, Taipale H, et al. Incidence of antipsychotic use in relation to diagnosis of Alzheimer’s disease among community-dwelling persons. Br J Psychiatry. 2015;207:444–449.
39. Nørgaard A, Jensen-Dahm C, Gasse C, et al. Time trends in antip­sychotic drug use in patients with dementia: a nationwide study. J Alzheimers Dis. 2015;49:211–220.
40. Bellelli G, Morandi A, Davis DH, et al. Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people. Age Ageing. 2014;43:496–502.
41. Hein C, Forgues A, Piau A, et al. Impact of polypharmacy on occur­rence of delirium in elderly emergency patients. J Am Med Dir Assoc. 2014;15:e11–e15.
42. Bo M, Martini B, Ruatta C, et al. Geriatric ward hospitalization reduced incidence delirium among older medical inpatients. Am J Geriatr Psychiatry. 2009;17:760–768.
43. Holt R, Young J, Heseltine D. Effectiveness of a multi-component intervention to reduce delirium incidence in elderly care wards. Age Ageing. 2013;42:721–727.
44. Ksiądzyna D, Szeląg A, Paradowski L. Overuse of proton pump inhibi­tors. Pol Arch Med Wewn. 2015;125:289–298.
45. Corleto VD, Festa S, Di Giulio E, et al. Proton pump inhibitor therapy and potential long-term harm. Curr Opin Endocrinol Diabetes Obes. 2014;21:3–8.
46. Fireman Z, Kopelman Y, Sternberg A. Central nervous system side effects after proton pump inhibitor treatment. J Clin Gastroenterol. 1997;25:718.
47. Heckmann JG, Birklein F, Neundörfer B. Omeprazole-induced delirium. J Neurol. 2000;247:56–57.
48. Teramura-Grönblad M, Bell JS, Pöysti MM, et al. Risk of death associ­ated with use of PPIs in three cohorts of institutionalized older people in Finland. J Am Med Dir Assoc. 2012;5:9–13.
49. Maggio M, Corsonello A, Ceda GP, et al. Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. JAMA Intern Med. 2013;173:518–523.
50. Kurti Z, Lovasz BD, Mandel MD, et al. Burden of Clostridium difficile infection between 2010 and 2013: trends and outcomes from an academic center in Eastern Europe. World J Gastroenterol. 2015;21:6728–6735.
51. Freeman R, Dabrera G, Lane C, et al. Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak of Salmonella Mikawasima in the UK, 2013. Epidemiol Infect. 2015;1:1–8.
52. Lambert AA, Lam JO, Paik JJ, et al. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One. 2015;10:e0128004. doi:10.1371/journal.pone.0128004.
53. Ruscin JM, Page RL 2nd, Valuck RJ. Vitamin B(12) deficiency associ­ated with histamine(2)-receptor antagonists and a proton-pump inhibi­tor. Ann Pharmacother. 2002;36:812–816.
54. Lam JR, Schneider JL, Zhao W, et al. Proton pump inhibitor and his­tamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310:2435–2442.
55. Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, et al. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am J Kidney Dis. 2015;66:775–782.
56. 12status, cogni­tive decline and dementia: a systematic review of prospective cohort studies. Br J Nutr. 2012;108:1948–1961.
57. Caplan JP, Chang G. Refeeding syndrome as an iatrogenic cause of delir­ium: a retrospective pilot study. Psychosomatics. 2010;51:419–424.
58. Sgarlata C, Rollone M, Ricevuti G, et al. A case of delirium due to severe hypomagnesemia occurred during long-term PPIs treatment. Eur Geriatr Med. 2013;4(Suppl 1):S137.
59. Wedemeyer RS, Blume H. Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update. Drug Saf. 2014;37:201–211.
60. Majumdar A, Capetillo-Zarate E, Cruz D, et al. Degradation of Alzheimer’s amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes. Mol Biol Cell. 2011;22:1664–1676.
61. Badiola N, Alcalde V, Pujol A, et al. The proton-pump inhibitor lanso­prazole enhances amyloid beta production. PLoS One. 2013;8:e58837. doi:10.1371/journal.pone.0058837.
62. Akter S, Hassan MR, Shahriar M, et al. Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software. Alzheimers Res Ther. 2015;7:79.
63. Sherwin E, Rea K, Dinan TG, et al. A gut (microbiome) feeling about the brain. Curr Opin Gastroenterol. Epub 2016 Jan 12.
64. Freedberg DE, Toussaint NC, Chen SP, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterol. 2015;149:883–885.
65. Imhann F, Bonder MJ, Vich Vila A, et al. Proton pump inhibitors affect the gut microbiome. Gut. Epub 2015 Dec 9. doi:10.1136/gutjnl-2015-310376.
66. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28:203–209.
67. Foster JA, McVey Neufeld KA. Gut-brain axis: how the micro­biome influences anxiety and depression. Trends Neurosci. 2013;36:305–312.
68. Naseribafrouei A, Hestad K, Avershina E, et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26:1155–1162.